Veru(VERU)
$2.31+0.17 (+7.94%)
VERU
Veru stock drug pipeline
$2.31
At close:+0.17 (+7.94%)
Want to see VERU full AI Analyst Report?
Veru (VERU) Drug Pipeline
2,015 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Veru Inc (VERU) have in its pipeline
Veru VERU is currently developing the following drugs: Enobosarm, Semaglutide Weekly Injection, Semaglutide, Enobosarm, Sabizabulin, Exemestane Monotherapy, Exemestane Plus Everolimus, Or Selective Estrogen Receptor Modulator, Enobosarm & Abemaciclib Combo, Non-Steroidal Ai, Or Steroidal Ai Or Fulvestrant, Sacituzumab Govitecan-Hziy, Sabizabulin, Sabizabulin/Sacituzumab Govitecan-Hziy Combo, Exemestane, Enobosarm, Veru-111, Veru-100, Veru-111, Enzalutamide, Abiraterone, Veru-944. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

